Moneycontrol Be a Pro
Get App
SENSEX NIFTY
you are here:

Jenburkt Pharma Ltd.

BSE: 524731 | NSE: | ISIN: INE354A01013 | SECTOR: Pharmaceuticals

Success
Alert
Please select a Day.
Info

BSE Live

Nov 18, 16:00
411.70 -0.15 (-0.04%)
Volume
AVERAGE VOLUME
5-Day
2,313
10-Day
2,061
30-Day
973
2,777
  • Prev. Close

    411.85

  • Open Price

    412.00

395.50

Today’s L/H

436.40
380.15

52 Wk L/H

678.00
329.50

L/U Price Band

494.20
  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

  •  VWAP
    402.36
  • Market Depth (18 Nov 2019)

    BUYSELL
    QTY PRICE PRICE QTY
    3 413.00 417.00 1
    11 412.50 418.00 9
    20 412.25 420.00 29
    25 411.30 424.00 10
    15 410.65 425.00 300
    0 Total Total 0
     Market Depth
    BUY 0
    SELL 0
    0%
    0%

NSE Live

(%)
Volume
No Data Available
  • Prev. Close

  • Open Price

Today’s L/H

52 Wk L/H

L/U Price Band

  • Bid Price (Qty.)

    ()

  • Offer Price (Qty.)

    ()

  • VWAP
    Series:
  • DELIVERY AVERAGES
    3-Day
    %
    5-Day
    %
    8-Day
    %
    Deliverables
    %
  • SMA
Jenburkt Pharma is not listed on NSE

Charts

  • Open : -
  • High : -
  • Low -
  • Close: -
  • Volume -

Valuation

    • Market Cap (Rs Cr.)
      188.94
    • P/E
      11.13
    • Book Value (Rs)
      168.79
    • Dividend (%)
      102.00
    • Market Lot
      1
    • Industry P/E
      28.63
    • EPS (TTM)
      36.98
    • P/C
      10.31
    • Price/Book
      2.44
    • Dividend Yield.(%)
      2.48
    • Face Value (RS)
      10.00
    • Deliverables (%)
      -

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

    • Market Cap (Rs Cr.)
      188.94
    • P/E
      -
    • Book Value (Rs)
      -
    • Dividend (%)
      102.00
    • Market Lot
      1
    • Industry P/E
      28.63
    • EPS (TTM)
      -
    • P/C
      -
    • Price/Book
      -
    • Dividend Yield.(%)
      2.48
    • Face Value (RS)
      -
    • Deliverables (%)
      -

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

Simple Moving Averages
DAYS BSE NSE
Click here to view the Open, High, Low, Close, Volume and Spread data.

Forum

Community Sentiments

Data not Available

What's your call on today?

Read 0 investor views

BUY SELL HOLD

Action in Jenburkt Pharma Ltd.

Pre-Opening Session Prices9:00 am - 9:15 am

BSE - No shares traded
NSE - No shares traded

Financials

Income Statement

  Sep 2019 Jun 2019 Mar 2019 Dec 2018 Sep 2018
Net Sales 34.18 20.84 35.13 32.28 31.98
Other Income 0.86 1.24 0.93 0.67 0.90
PBDIT 7.42 -0.61 8.91 6.36 7.07
Net Profit 5.55 0.06 6.89 4.46 5.74

Balance Sheet

Standalone Mar 2019 Mar 2018
Total Share Capital 4.59 4.59
Networth 77.47 61.26
Total Debt 7.47 0.24
Net Block 9.59 9.57
Investments 5.38 5.42
Total Assets 84.93 61.50

Historical Prices

On
Current Price %Gain / Loss
Open Price 626.00 412.00
-34.19
High Price 640.00 436.40
-31.81
Low Price 625.00 395.50
-36.72
Close Price 629.60 411.85
-34.59
Volume 773 2,777
259.25
On
Current Price %Gain / Loss
No Record Found
Click Here to view the Open, High, Low, Close, Volume and Historic data for
Index Price Change %Chg
NIFTY 50 11884.50 -11.00 -0.09
SENSEX 40284.19 -72.50 -0.18
NIFTY BANK 30992.10 -16.30 -0.05
NIFTY IT 15295.30 -15.30 -0.10
S&P BSE Smallcap 13362.61 36.21 0.27
Index Price Change %Chg
Nasdaq (Nov 18) 8,528.97 -11.86 -0.14
CAC (Nov 18) 5,929.79 -9.48 -0.16
DAX (Nov 18) 13,207.01 -34.74 -0.26
FTSE (Nov 18) 7,307.70 4.76 0.07
SGX Nifty (Nov 18) 11,928.00 5.00 0.04

CORPORATE ACTION

Date Agenda
Nov 05, 2019 Audited Results
Jul 30, 2019 Quarterly Results
May 28, 2019 Audited Results & Final Dividend
Feb 05, 2019 Quarterly Results
Type Dividend% Ex-Dividend date
Final 102.00 Jul 22, 2019
Final 60.00 Jul 23, 2018
Interim 30.00 Mar 27, 2018
Final 81.00 Jul 21, 2017
Final 9.00 Jul 19, 2016
Ratio Announcement Date Ex-Bonus
No Bonus Information is available for Jenburkt Pharma
Old FV New FV Ex-Split
No Splits Information is available for Jenburkt Pharma
Ratio Premium Ex-Bonus
No Rights Information is available for Jenburkt Pharma
Date Agenda
Jul 30, 2019 -
Jul 31, 2018 -
- Buy Back of Shares
Oct 27, 2017 -
Jul 31, 2017 -

Dividend Summary

For the year ending March 2019 Jenburkt Pharma has declared an equity dividend of 102.00% amounting to Rs 10.2 per share.

The company has a good dividend track report and has consistently declared dividends for the last 5 years.

SHARE HOLDING PATTERN & MUTUAL FUND HOLDING

Share Holding Pattern in (%)

Standalone June 2019 March 2019 December 2018 September 2018
Promoters 45.6 45.6 45.6 45.6
Pledged 0 0 0 0
FII/FPI 2.22 2.22 2.11 1.7
Total DII 8.27 7.95 7.99 7.88
Fin.Insts 0 0 0 0
Insurance Co 0 0 0 0
MF 0 0 0 0
Others DIIs 8.27 7.95 7.99 7.88
Others 43.91 44.23 44.29 44.82
Total 100 100 99.99 100

Mutual Funds Holding

Data not available

PEERS COMPARISON

Company Name Last Price % Change 52 Wk High 52 Wk Low Market Cap Sales Qtr Net Profit Qtr
Jenburkt Pharma 411.70 -0.04 678.00 380.15 188.94 122.64 19.80
Sun Pharma 424.35 2.28 616.50 350.40 101815.78 10,303.21 816.60
Divis Labs 1731.60 -0.94 1773.00 1214.25 45968.54 4,879.66 1,332.65
Dr Reddys Labs 2736.05 0.21 2965.20 2065.30 45458.31 10,625.50 1,277.30
Cipla 459.75 -0.72 645.00 389.55 37060.76 12,374.01 1,888.41

COMPANY OVERVIEW

Jenburkt Pharmaceuticals Limited is an India-based company engaged pharmaceutical formulations. The Company is engaged in manufacturing and marketing of speciality and pharmaceutical formulations and healthcare products. The Company manufactures products in two types divsions: consumer divsion and pharmaceutical division. The Company`s products under consumer divsion include nocal tablets, nocal sachet, and nocal granular. The Company`s products uner the pharmaceutical division include anti-arthritic, anti-osteoporotic, antibiotics, anti-diabitic, neuropathy, anti-inflammory analgesics, gastro intenstinal, dermatologicals, aphrodisiac, anti-cough, cold and allergy, anti-ulcerants, and anti-malarial. The Company has approximately 50 brands, which are promoted through doctors.

COMPANY INFORMATION

  • Registered Office

  • Registrars

  • Management

    • Name

      Designation

    • Ashish U Bhuta

      Chairman & Managing Director

    • Dilip H Bhuta

      WholeTime Director & CFO

    • Bharat V Bhate

      Ind. Non-Executive Director

    • Rameshchandra J Vora

      Ind. Non-Executive Director

    • Arun R Raskapurwala

      Ind. Non-Executive Director

  • Listing

    Whether The Company Forms A Part Of The Following Indices -
    • Sensex

      No

    • Nifty

      No

    • Bse-100

      No

    • Bse-200

      No

    • S&P CNX 500

      No

    • CNX Midcap

      No

About Jenburkt Pharma Ltd.

Jenburkt Pharma is in the Pharmaceuticals sector.

It is listed on the BSE with a BSE Code of 524731.

Related Searches